aTransForm Pharmaceuticals, Inc., 29 Hartwell Avenue, Lexington, MA 02421, United States
bDepartment of Pharmaceutical Sciences, Drug Research Laboratory, University of Tennessee Health Science Center, Memphis, TN, United States
Abstract:
A novel lipid formulation containing fenofibrate in omega-3 oil was developed using a novel high-throughput screening platform. The optimized formulation combines the cardiovascular health benefits from omega-3 oil with the potent lipid-regulating effect of fenofibrate. When tested against the current marketed product Tricor® in healthy human volunteers, the new formulation was shown to be equivalent to Tricor®.